{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:24:38Z","timestamp":1772166278828,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early-stage primary gastrointestinal (GI) low-grade B-cell lymphoma shows good therapeutic response to primary radiotherapy. However, there is no clear guideline for the evaluation of response to radiation therapy currently. The aim of this study was to analyze the relationship between the best response time and the clinical course after radiotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients who underwent radiotherapy for treatment of primary GI low-grade B-cell lymphoma from September 2007 to December 2018 at Seoul St. Mary\u2019s Hospital were included. Early responders were defined by best response within 6\u2009months after radiotherapy, and delayed responders after 6\u2009months. Clinical and pathological factors associated with delayed response and survival analyses were performed to investigate the recurrence and survival during follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 43 patients were evaluated and the number of gastric mucosa-associated lymphoid tissue and duodenal follicular lymphoma was 36 and 7, respectively. All of 43 patients showed complete remission to radiotherapy and the best response time after radiotherapy was a median of 3\u2009months. There were 8 delayed responders with a median duration of 8.9\u2009months. Early and delayed responders were characterized by a significant difference in depth of invasion beyond the mucosal layer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Delayed responders did not show differences in oncological outcomes compared with early responders. They were allowed to watch and wait for an additional 6 to 12\u2009months without further treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-020-01649-6","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T06:03:10Z","timestamp":1598853790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Analysis of the response time to involved-field radiotherapy in primary gastrointestinal low-grade B-cell lymphoma"],"prefix":"10.1186","volume":"15","author":[{"given":"Kyu Hye","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Eun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Sin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo-Hyun","family":"O","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Woo","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Ock","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok-Goo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,31]]},"reference":[{"key":"1649_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000350051","volume":"87","author":"S Nakamura","year":"2013","unstructured":"Nakamura S, Matsumoto T. Gastrointestinal lymphoma: recent advances in diagnosis and treatment. Digestion. 2013;87:182\u20138.","journal-title":"Digestion"},{"key":"1649_CR2","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1002\/cncr.11415","volume":"97","author":"S Nakamura","year":"2003","unstructured":"Nakamura S, Matsumoto T, Iida M, Yao T, Tsuneyoshi M. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer. 2003;97:2462\u201373.","journal-title":"Cancer"},{"key":"1649_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3748\/wjg.v17.i6.697","volume":"17","author":"P Ghimire","year":"2011","unstructured":"Ghimire P, Wu GY, Zhu L. Primary gastrointestinal lymphoma. World J Gastroenterol. 2011;17:697\u2013707.","journal-title":"World J Gastroenterol"},{"key":"1649_CR4","doi-asserted-by":"publisher","first-page":"107327481877825","DOI":"10.1177\/1073274818778256","volume":"25","author":"LM Juarez-Salcedo","year":"2018","unstructured":"Juarez-Salcedo LM, Sokol L, Chavez JC, Dalia S. Primary gastric lymphoma, epidemiology, clinical diagnosis, and treatment. Cancer Control. 2018;25:1073274818778256.","journal-title":"Cancer Control"},{"key":"1649_CR5","doi-asserted-by":"publisher","first-page":"706","DOI":"10.5009\/gnl15510","volume":"10","author":"EJ Gong","year":"2016","unstructured":"Gong EJ, Ahn JY, Jung HY, Park H, Ko YB, Na HK, Jung KW, Kim Do H, Lee JH, Choi KD, Song HJ, Lee GH, Kim JH. Helicobacter pylori eradication therapy is effective as the initial treatment for patients with H. pylori-negative and disseminated gastric mucosa-associated lymphoid tissue lymphoma. Gut Liver. 2016;10:706\u201313.","journal-title":"Gut Liver"},{"key":"1649_CR6","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1093\/annonc\/mdn760","volume":"20","author":"A Stathis","year":"2009","unstructured":"Stathis A, Chini C, Bertoni F, Proserpio I, Capella C, Mazzucchelli L, Pedrinis E, Cavalli F, Pinotti G, Zucca E. Long-term outcome following helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. J Ann Oncol. 2009;20:1086\u201393.","journal-title":"J Ann Oncol"},{"key":"1649_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3109\/10428199709050889","volume":"26","author":"G Pinotti","year":"1997","unstructured":"Pinotti G, Zucca E, Roggero E, Pascarella A, Bertoni F, Savio A, Savio E, Capella C, Pedrinis E, Saletti P, Morandi E, Santandrea G, Cavalli F. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma. 1997;26:527\u201337.","journal-title":"Leuk Lymphoma"},{"key":"1649_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bpg.2009.12.002","volume":"24","author":"BM Aleman","year":"2010","unstructured":"Aleman BM, Haas RL, van der Maazen RW. Role of radiotherapy in the treatment of lymphomas of the gastrointestinal tract. J Best Pract Res Clin Gastroenterol. 2010;24:27\u201334.","journal-title":"J Best Pract Res Clin Gastroenterol"},{"key":"1649_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","volume":"92","author":"J Yahalom","year":"2015","unstructured":"Yahalom J, Illidge T, Specht L, Hoppe RT, Li YX, Tsang R, Wirth A. Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the international lymphoma radiation oncology group. Int J Radiat Oncol Biol Phys. 2015;92:11\u201331.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1649_CR10","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1200\/JCO.1996.14.4.1282","volume":"14","author":"MP Mac Manus","year":"1996","unstructured":"Mac Manus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol. 1996;14:1282\u201390.","journal-title":"J Clin Oncol"},{"key":"1649_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1182\/blood-2018-04-843540","volume":"133","author":"JL Brady","year":"2019","unstructured":"Brady JL, Binkley MS, Hajj C, Chelius M, Chau K, Balogh A, Levis M, Filippi AR, Jones M, Mac Manus M, Wirth A, Oguchi M, Vistisen AK, Andraos TY, Ng AK, Aleman BMP, Choi SH, Kirova Y, Hardy S, Reinartz G, Eich HT, Bratman SV, Constine LS, Suh CO, Dabaja B, El-Galaly TC, Hodgson DC, Ricardi U, Yahalom J, Hoppe RT, et al. Definitive radiotherapy for localized follicular lymphoma staged by (18)F-FDG PET-CT: a collaborative study by ILROG. Blood. 2019;133:237\u201345.","journal-title":"Blood"},{"key":"1649_CR12","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1200\/JCO.2003.09.542","volume":"21","author":"RL Haas","year":"2003","unstructured":"Haas RL, Poortmans P, de Jong D, Aleman BM, Dewit LG, Verheij M, Hart AA, van Oers MH, van der Hulst M, Baars JW, Bartelink H. High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. J Clin Oncol. 2003;21:2474\u201380.","journal-title":"J Clin Oncol"},{"key":"1649_CR13","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1200\/JCO.2001.19.18.3874","volume":"19","author":"P Koch","year":"2001","unstructured":"Koch P, del Valle F, Berdel WE, Willich NA, Reers B, Hiddemann W, Grothaus-Pinke B, Reinartz G, Brockmann J. Temmesfeld A: Primary gastrointestinal non-Hodgkin\u2019s lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma\u2014results of the prospective German multicenter study GIT NHL 01\/92. J Clin Oncol. 2001;19:3874\u201383.","journal-title":"J Clin Oncol"},{"key":"1649_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/hon.743","volume":"23","author":"RW Tsang","year":"2005","unstructured":"Tsang RW, Gospodarowicz MK. Radiation therapy for localized low-grade non-Hodgkin's lymphomas. J Hematol oncol. 2005;23:10\u20137.","journal-title":"J Hematol oncol"},{"key":"1649_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.radonc.2008.02.012","volume":"87","author":"C Vrieling","year":"2008","unstructured":"Vrieling C, de Jong D, Boot H, de Boer JP, Wegman F, Aleman BM. Long-term results of stomach-conserving therapy in gastric MALT lymphoma. J Radiotherapy. 2008;87:405\u201311.","journal-title":"J Radiotherapy"},{"key":"1649_CR16","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1002\/cncr.25226","volume":"116","author":"JS Goda","year":"2010","unstructured":"Goda JS, Gospodarowicz M, Pintilie M, Wells W, Hodgson DC, Sun A, Crump M, Tsang RW. Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy. J Cancer. 2010;116:3815\u201324.","journal-title":"J Cancer"},{"key":"1649_CR17","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.3748\/wjg.v19.i36.6062","volume":"19","author":"S-W Kim","year":"2013","unstructured":"Kim S-W, YCA DHL, Kim WS, Kim SJ, Ko YH, Kim K-M. Clinical outcomes of radiation therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma. J World J Gastroenterol. 2013;19:6062.","journal-title":"J World J Gastroenterol"},{"key":"1649_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00066-019-01538-2","volume":"196","author":"K Elsayad","year":"2020","unstructured":"Elsayad K, Reinartz G, Oertel M, Rehn S, Eismann J, Scobioala S, Berssenbr\u00fcgge H, Eter N, Weishaupt C, Schmidt HH, Friedrichs B, Gr\u00fcnewald I, Hartmann W, Lenz G, Wardelmann E, Willich N, Eich HT. Radiotherapy of extranodal low-grade follicular and marginal zone lymphomas: long-term follow-up of 159 patients. Strahlenther Onkol. 2020;196:117\u201325.","journal-title":"Strahlenther Onkol"},{"key":"1649_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","volume":"100","author":"L Lowry","year":"2011","unstructured":"Lowry L, Smith P, Qian W, Falk S, Benstead K, Illidge T, Linch D, Robinson M, Jack A, Hoskin P. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol. 2011;100:86\u201392.","journal-title":"Radiother Oncol"},{"key":"1649_CR20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.4143\/crt.2018.190","volume":"51","author":"H Lee","year":"2019","unstructured":"Lee H, Oh D, Yang K, Ko YH, Ahn YC, Kim WS, Kim SJ. Radiation therapy outcome and clinical features of duodenal-type follicular lymphoma. Cancer Res Treat. 2019;51:547\u201355.","journal-title":"Cancer Res Treat"},{"key":"1649_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/gut.48.3.297","volume":"48","author":"A Ruskone-Fourmestraux","year":"2001","unstructured":"Ruskone-Fourmestraux A, Lavergne A, Aegerter P, Megraud F, Palazzo L, De Mascarel A, Molina T, Rambaud JL. Predictive factors for regression of gastric MALT lymphoma after anti-helicobacter pyloritreatment. Gut. 2001;48:297\u2013303.","journal-title":"Gut"},{"key":"1649_CR22","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/0140-6736(93)91408-E","volume":"342","author":"T Hussell","year":"1993","unstructured":"Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to helicobacter pylori. Lancet. 1993;342:571\u20134.","journal-title":"Lancet"},{"key":"1649_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/978-3-642-57054-4_15","volume":"156","author":"A Savio","year":"2000","unstructured":"Savio A, Zamboni G, Capelli P, Negrini R, Santandrea G, Scarpa A, Fuini A, Pasini F, Ambrosetti A, Paterlini A, Buffoli F, Angelini GP, Cesari P, Rolfi F, Graffeo M, Pascarella A, Valli M, Mombello A, Ederle A, Franzin G. Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: true relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol's adequacy. Recent Results Cancer Res. 2000;156:116\u201324.","journal-title":"Recent Results Cancer Res"},{"key":"1649_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/hon.1022","volume":"30","author":"C Vetro","year":"2012","unstructured":"Vetro C, Romano A, Chiarenza A, Conticello C, Donnarumma D, Gorgone A, Coppolino F, Palumbo GA, Bonanno G, Di Raimondo F. Endoscopic ultrasonography in gastric lymphomas: appraisal on reliability in long-term follow-up. Hematol Oncol. 2012;30:180\u20135.","journal-title":"Hematol Oncol"},{"key":"1649_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.gie.2006.05.009","volume":"65","author":"LM El-Zahabi","year":"2007","unstructured":"El-Zahabi LM, Jamali FR, El H II, Naja M, Salem Z, Shamseddine A, El-Saghir NS, Zaatari G, Geara F, Soweid AM. The value of EUS in predicting the response of gastric mucosa-associated lymphoid tissue lymphoma to helicobacter pylori eradication. Gastrointest Endosc. 2007;65:89\u201396.","journal-title":"Gastrointest Endosc"},{"key":"1649_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.7326\/0003-4819-131-2-199907200-00003","volume":"131","author":"G Steinbach","year":"1999","unstructured":"Steinbach G, Ford R, Glober G, Sample D, Hagemeister FB, Lynch PM, McLaughlin PW, Rodriguez MA, Romaguera JE, Sarris AH, Younes A, Luthra R, Manning JT, Johnson CM, Lahoti S, Shen Y, Lee JE, Winn RJ, Genta RM, Graham DY, Cabanillas FF. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med. 1999;131:88\u201395.","journal-title":"Ann Intern Med"},{"key":"1649_CR27","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1136\/gut.48.4.454","volume":"48","author":"S Nakamura","year":"2001","unstructured":"Nakamura S, Matsumoto T, Suekane H, Takeshita M, Hizawa K, Kawasaki M, Yao T, Tsuneyoshi M, Iida M, Fujishima M. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of helicobacter pylori. Gut. 2001;48:454\u201360.","journal-title":"Gut"},{"key":"1649_CR28","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/gut.2010.224949","volume":"60","author":"A Ruskon\u00e9-Fourmestraux","year":"2011","unstructured":"Ruskon\u00e9-Fourmestraux A, Fischbach W, Aleman BMP, Boot H, Du MQ, Megraud F, Montalban C, Raderer M, Savio A, Wotherspoon A. EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut. 2011;60:747\u201358.","journal-title":"Gut"},{"key":"1649_CR29","doi-asserted-by":"crossref","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA, Alliance AL, Lymphoma G, Eastern Cooperative Oncology G, European Mantle Cell Lymphoma C, Italian Lymphoma F, European Organisation for R, Treatment of Cancer\/Dutch Hemato-Oncology G, Grupo Espa\u00f1ol de M\u00e9dula \u00d3, German High-Grade Lymphoma Study G, German Hodgkin's Study G, Japanese Lymphorra Study G, Lymphoma Study A, Group NCT, Nordic Lymphoma Study G, Southwest Oncology G, United Kingdom National Cancer Research I: Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 2014, 32:3059\u20133068.","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"1649_CR30","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/MCG.0b013e3181d6b543","volume":"44","author":"A Zullo","year":"2010","unstructured":"Zullo A, Hassan C, Andriani A, Cristofari F, Cardinale V, Spinelli GP, Tomao S, Morini S. Primary low-grade and high-grade gastric MALT-lymphoma presentation. J Clin Gastroenterol. 2010;44:340\u20134.","journal-title":"J Clin Gastroenterol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-020-01649-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-020-01649-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-020-01649-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T19:52:40Z","timestamp":1630353160000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-020-01649-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,31]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1649"],"URL":"https:\/\/doi.org\/10.1186\/s13014-020-01649-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-28812\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-28812\/v2","asserted-by":"object"}]},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,31]]},"assertion":[{"value":"12 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of the Korea Association of Health Promotion (approval No. KC19RESI0121). Informed consent was waived due to the retrospective study design.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have given consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"210"}}